AUSTRALIAN Securities Exchange (ASX) listed medtech firm, MedAdvisor (MDR), has entered a 48-hour trading halt pending the release of an announcement regarding a funding facility.
The company said the announcement would be made prior to the commencement of trading on Thu 06 May.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 May 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 May 21